Dr. Pavan Reddy, director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, has been elected to the newest class of American Association for the Advancement of Science (AAAS) Fellows. Reddy is recognized for his work to revolutionize the care of patients to control graft-versus-host disease (GVHD), with seminal insights into immunological modulation of this challenging disease.
Reddy's research in basic and translational transplantation immunology focuses on investigating the immunological and tissue intrinsic mechanisms underpinning the major complication and the beneficial effects of allogeneic hematopoietic stem cell transplantation, namely GVHD and graft-versus-leukemia (GVL), respectively.
Reddy joined Baylor as director of the Duncan Cancer Center in 2022. He obtained his medical degree from Osmania Medical College in India. He completed his residency in internal medicine at the University of Missouri and fellowships in hematology-oncology and blood and bone marrow transplantation at the University of Michigan, Ann Arbor.
